Ce mémoire présente l’étude de certains effets pharmacologiques de nouveaux analogues synthétiques des cannabinoïdes. Un des objectifs de longue date des recherches sur les cannabinoïdes a été la découverte de puissants analogues synthétiques de substances naturelles, qui pourraient être développés comme médicaments. Cela nécessite, entre autres, qu’ils soient exempts d’effets psychotropes qui caractérisent l’usage récréatif du Cannabis. Le moteur derrière cet objectif a été la longue histoire de l’usage du Cannabis comme substance médicale, en particulier dans le traitement de la douleur et de l’inflammation. Parmi les nombreux effets pharmacologiques des cannabinoïdes, deux sont d’un grand intérêt thérapeutique : l’effet antiprolifératif sur les cellules tumorales et l’effet anti-angiogène. Dans ce mémoire, l’étude de ces deux effets a été réalisée sur des cultures cellulaires tumorales et endothéliales humaines. Les tests de prolifération sur les deux types de cellules n’ont pas montré de cytotoxicité. Ce qui a permis de poursuivre l’étude de l’effet anti-angiogène, et qui a mis fin à l’étude de l’effet anti-tumoral. L’inhibition de l’angiogénèse a été investiguée en réalisant des tests de recolonisation d’une zone dénudée dans une monocouche de cellules endothéliales et des tests de formation de microtubules sur matrice gélifiée. L’effet anti-angiogène n’a pas pu être évalué à cause de problèmes de contamination, néanmoins certaines molécules montrent un effet anti-migratoire. L’absence de cytotoxicité et l’analogie structurale avec le -tétrahydrocannabinol encourage à continuer l’investigation des effets pharmacologiques de ces nouvelles molécules synthétiques. Il serait aussi pertinent d’étudier, dans une thèse de doctorat, les mécanismes d’actions moléculaires par lesquels agissent ces molécules. / This thesis aims to assess the pharmacological effects of new synthetic cannabinoid analogs. A long-standing goal in cannabinoid research has been the discovery of potent synthetic analogs of the natural substances that might be developed as clinically useful drugs. This requires, among other things, that they be free of the psychotropic effects that characterize the recreational use of Cannabis. An important driving force for this goal is the long history of the use of Cannabis as a medicinal agent especially in the treatment of pain and inflammation. Among the many pharmacological effects of cannabinoids, two are of great therapeutic value: the anti-proliferative effect on tumor cells and anti-angiogenic effect. In this thesis, the study of these two effects has been conducted on tumoral and endothelial culture cell. The proliferation tests on both types of cells showed no cytotoxicity. This allowed further study of the anti-angiogenic effect, and ended the study of anti-tumoral effect. Inhibition of angiogenesis has been investigated by performing recolonization tests of a denuded area on endothelial cell monolayer and microtubules formation tests on gel matrix. This effect could not be evaluated because of contamination problems; however, some molecules show anti-migration effects. The absence of cytotoxicity and structural analogy with -tetrahydrocannabinol encourages the investigation in pharmacological effects of these new synthetic molecules. It would also be interesting to study in a doctoral thesis, the molecular mechanisms of action involved.

Syftet med denna studie är att utröna varför personer väljer att använda syntetiska cannabinoider. Vidare ämnade studien undersöka om personer som använder syntetiska cannabinoider också använder andra droger. Samtidigt har studien målet att ta reda på i vilken utsträckning drogens laglighet inverkar vid valet att använda drogen. Studien är kvantitativ. Undersökningen utfördes genom en webbenkät som besvarades av totalt 356 respondenter. Av dessa hade 171 personer använt syntetiska cannabinoider. I resultatet framkom att anledningarna till att använda drogen är flera, men de främsta visade sig vara laglighet, nyfikenhet, tillgänglighet, ruset samt att det ej visar sig vid urinprov. Personer som använder syntetiska cannabinoider har en tendens att också använda flera andra droger. Drogens laglighet visade sig ha en relativt stor inverkan på valet att använda den. Det visade sig också att män i större utsträckning använder syntetiska cannabinoider i jämförelse med kvinnor. / The purpose of this study is to examine why people choose to use synthetic cannabinoids. Furthermore, the study intended to investigate whether people who use synthetic cannabinoids also using other drugs. Meanwhile the study has the objective to find out to what extent the drug affects the legality of the choice to use the drug. The study is quantitative. The survey was conducted through an online survey and was answered by a total of 356 respondents. Of these, 171 people used synthetic cannabinoids. The result showed that the reason for using the drug are several, but the main proved were legality, curiosity, availability, intoxication and that it is not revealed by urine testing. People using synthetic cannabinoids have a tendency to also use several other drugs. The legacy of the drug was found to have a relatively large impact on the decision to use it. It was also found that men in greater occurrence use synthetic cannabinoids compared to women.

Introduction: Over recent decades, there has been an increase in the availability and use of Novel Psychoactive Substances (NPS) all over the world. They include several classes of chemicals that mimic the effects of illicit drugs and have been purposefully introduced into the market to circumvent or undermine the purpose of legal regulation. Currently, there is information lacking on the pharmacology of these substances; however, the increasing number of cases and outbreaks of intoxications/deaths is becoming a cause for deepening concern. Multi-disciplinary research in the fields of biology, chemistry, clinical medicine and web analysis is needed to develop responses against this tidal wave. Aim: The overall aim of this project is to gain insights into pharmacological, neurochemical and molecular properties of selected NPS to provide a reliable background needed for detection, assessment, and management of NPS-related harms. A range of approaches and methodologies was employed and a spectrum of different fields of knowledge has been engaged to gain some understanding into the complex multi-faceted phenomenon of NPS. Methods: Different substances have been selected as targets for the present project according to the clinical pattern of toxicity raised by their worldwide use and the lack of scientific knowledge available about them. The methods employed were: in vitro quantitative autoradiography (to evaluate the binding properties of the novel SCs BB-22, 5F-PB-22, 5F-AKB-48 and STS-135 at the cannabinoid receptor type 1 and N-methyl-D-aspartate receptor; and the binding properties of the synthetic stimulants 5-IT and 2-DPMP at the dopamine transporter in rat brain slices); in vitro Fast Scan Cyclic Voltammetry (to assess the effects of BB-22 on evoked dopamine efflux and dopamine re-uptake half-life in nucleus accumbens brain slices); in vivo microdialysis (to monitor dopamine release in terminal areas of the reward system after acute administration of the synthetic cannabinoids BB-22, 5F-PB-22, 5F-AKB-48 and STS-135; the dieting aid compound 2,4-DNP; the synthetic stimulants 2-DPMP and D2PM in freely moving animals); in silico molecular docking (to investigate the intermolecular interactions of the SCs BB-22, 5F-PB-22, 5F-AKB-48 and STS-135, and other referent compounds, with a homology model of the rodent cannabinoid receptor type 1 (CB1R) and the crystal structure of the human CB1R); and a web-based analysis approach (to analyse the information provided by a range of fora communities on 4,4'-DMAR use, additionally critical reviewing the available evidence-based literature on this topic). Results: Our in vitro quantitative autoradiography studies, confirmed that the index compounds BB-22, 5F-PB-22, 5F-AKB-48 and STS-135, behave as highly potent CB1R ligands able to compete with the radioligand [3H]CP-55,940 in cortical and striatal brain slices. On the other hand, all synthetic cannabinoids tested were unable to compete with the radioligand [3H]MK-801 in the same cerebral areas, rejecting the hypothesis of their potential binding to the N-methyl-D-aspartate receptor (NMDAR) at all concentrations investigated. Consistent with previous in vitro studies, 5-IT and 2-DPMP behaved as highly potent dopamine transporter (DAT) ligands able to compete with the radioligand [125 I]RTI-121 in a concentration-dependent way in the Caudate Putamen (CPu) and Nucleus Accumbens (NAc) brain slices. Notably, 2-DPMP was able to displace the radioligand in both cerebral regions, starting from lower concentrations compared to 5-IT. In vitro Fast Scan Cyclic Voltammetry findings demonstrated that local application of the synthetic cannabinoid BB-22 in brain slices, was unable to change evoked dopamine efflux and dopamine reuptake time-constant in the NAc shell at any doses tested. The results obtained would suggest the relative contributions of complex neuronal circuits, either within or outside the NAc, whose modulation would interfere with the interactions between BB-22 and dopaminergic neurons and represent critical pathways accounting for some of the rewarding properties of BB-22 exposure. In vivo microdialysis outcomes suggested that all SCs tested could increase dopamine release in the NAc shell at specific doses, while no changes in dopamine output were observed in other areas of the reward system, namely NAc core and medial prefrontal cortex (mPFCx) after BB-22 administration. These outcomes provided a circumstantial pre-clinical evidence for a greater putative abuse liability of SCs compared to the natural compound found in cannabis (Δ9‐THC). Furthermore, the acute treatment with 2,4-DNP did not cause any change in dopamine release in the NAc shell and CPu rejecting the hypothesis of psychoactivity of this substance at the dose tested. On the other hand, the synthetic stimulant 2-DPMP elicited a comparable increase of dopamine (DA) release in the NAc shell and CPu at the higher doses tested, while D2PM caused a selective increase of DA release in the NAc shell, providing a circumstantial preclinical evidence for a putative abuse liability of this compound at the highest dose assessed. The in silico molecular docking studies demonstrated that the SCs BB-22, 5F-PB-22, 5F-AKB-48 and STS-135 interact with CB1 receptor residues that, according to previous mutation and computational studies, are considered crucial for synthetic cannabinoid binding recognition. Additionally, they share some interacting residues with other aminoalkylindole derivatives (e.g. WIN-55,212-2). The web-based analysis focused on 4,4'-DMAR, suggested that fora members co-operate in exchanging an extensive body of knowledge about this drug, and the recurring topics of discussion include: routes of administration and dosages; desired and undesired effects; comparison and association with other drugs and medications; overall impression; provision of harm reduction advice. This approach has been useful to better understand some of the clinical and psychopharmacological issues pertaining to 4,4'-DMAR. Conclusions: Overall, these studies provided new pharmacological, neurochemical and molecular knowledge on a range of Novel Psychoactive Substances essential for identifying potential therapeutical approaches against their use/abuse. The novelty of this project lies in the adoption of a multi-disciplinary approach involving a range of methodologies from different areas of expertise (neurobiology, pharmacology, chemistry, netnography) all integrated to clarify some aspects of the index NPS, which were not yet available in the current literature. Additional studies are needed to better explain short and long-term effects of the index NPS, their abuse potential, and their interactions with other drugs of abuse.

Orientadora: Profa. Dra. Káthia Maria Honório / Dissertação (mestrado) - Universidade Federal do ABC, Programa de Pós-Graduação em Ciência & Tecnologia - Química, 2014. / Polimeros de impressao molecular (MIPs) sao materiais sinteticos que possuem sitios de reconhecimento molecular especificos para determinado analito de interesse (molecula molde), e tem sido empregados para a pre-concentracao e extracao em amostras complexas, considerando a maior seletividade em relacao aos sorventes convencionais empregados na extracao em fase solida. A escolha dos reagentes utilizados na sintese de um MIP deve ser criteriosa, a fim de que sejam criados sitios de ligacoes especificos. Metodos computacionais de Quimica Teorica podem ser empregados para racionalizar o planejamento de MIPs, por intermedio do estudo de parametros fisico-quimicos das moleculas envolvidas e as interacoes que ocorrem no sistema de pre-polimerizacao. Com a utilizacao de metodos de quimica quantica, foi objetivo desse trabalho o estudo previo das interacoes entre as moleculas moldes e os possiveis reagentes empregados na sintese de MIPs, como forma de predicao das melhores interacoes que promovam um MIP de desempenho ideal. O estudo teorico foi direcionado para a molecula de ¿¢9-tetrahidrocanabinol (¿¢9-THC), substancia presente na planta Cannabis sativa e que e a substancia ilicita mais produzida e consumida mundialmente, e seu principal metabolito de excrecao urinario, o 11-nor-9-carboxi-¿¢9-THC (THC-COOH). A simulacao computacional foi realizada utilizando a Teoria do Funcional da Densidade (DFT), e a metodologia envolveu a comparacao das energias de interacao (¿¢E) dos adutos de pre-polimerizacao entre a molecula molde e os reagentes de sintese. Com os resultados das simulacoes, verificou-se que as melhores interacoes ocorrem quando o monomero utilizado tem caracteristica acida, como o acido acrilico e o acido metacrilico; e que o solvente mais adequado para a sintese sao os que apresentam baixa constante dieletrica, como o cloroformio e o tolueno, por interferirem menos na formacao do complexo de interacao entre a molecula molde e o monomero na etapa de pre-polimerizacao. Detalhes das interacoes existentes entre as moleculas do meio reacional tambem foram analisadas e forneceram informacoes sobre a possivel competicao entre as moleculas no acesso aos sitios de interacao das moleculas moldes, informacao crucial para obtencao de MIPs seletivos e de grande afinidade a molecula molde desejada. A partir das predicoes do estudo computacional, os MIPs de THC-COOH foram sintetizados com os monomeros indicados, juntamente com o polimero nao impresso (NIP), em alguns dos solventes simulados (agua, acetonitrila, metanol e agua), para avaliacao da interferencia do solvente na eficiencia do MIP obtido. Foi realizada a analise dos MIPs por espectroscopia vibracional na regiao do infravermelho, e avaliada as bandas de absorcao nas regioes dos grupos C=O e O-H, para analise da formacao de interacoes por ligacao de hidrogenio. Concluiu-se, portanto, que sem substituir os ensaios experimentais, a abordagem computacional pode ser utilizada como uma ferramenta preliminar e complementar a selecao experimental. / Molecularly imprinted polymers (MIPs) are synthetic materials with specific sites of molecular recognition for a given analyte of interest (template molecule), and have been used for the extraction and pre-concentration in complex samples, considering the higher selectivity presented in relation to the sorbent employed in conventional solid phase extraction. The choice of the reagents used in the synthesis of a MIP must be chosen carefully, so that site-specific linkages are created. Computational methods in Theoretical Chemistry can be used to rationalize the planning of MIPs through the study of physico-chemical parameters of the molecules involved and the interactions that occur in the pre-polymerization system. Using quantum chemical methods, the aim of this study was a preliminary investigation of the interactions between the template molecules and the possible reagents used in the synthesis of MIPs, as a way to predict the best interactions that promote MIPs with optimal performance. The theoretical study was directed to the molecule of Ä9-tetrahydrocannabinol (Ä9-THC), present in the plant Cannabis sativa, and that is the illicit substance most widely produced and consumed globally, as well as its major metabolite urinary excretion, 11 -nor-9-carboxy-Ä9-THC (THC-COOH). The computational simulation was performed using the Density Functional Theory (DFT), and the methodology involved the comparison of the interaction energies (ÄE) of adducts in pre-polymerization between the template molecule and reagents for synthesis. From the results of the simulations, it was found that the best interactions occur when the monomer has acid characteristic, such as acrylic acid and methacrylic acid; and that the most suitable solvent for synthesis are those with low dielectric constant such as toluene and chloroform, by interfering less in the formation of complex interaction between the template molecule and monomer in the pre-polymerization step. Details of the existing interactions between the molecules of the reactional medium were analyzed and provided information about the possible competition between the molecules in the access to the interaction sites of the template molecules, which is a crucial information for obtaining selective MIPs and with high affinity to the template molecule desired. From the computational predictions obtainde in this study, the MIPs of THC-COOH was synthesized with the indicated monomers, and also a non-imprinted polymer (NIP), considering some of simulated solvents (water, acetonitrile, methanol and water) for evaluation of the interference of solvent in the efficiency of the MIP obtained. Analyses on the formed MIPs were performed by spectroscopy in the infrared region, and the absorption bands in the regions of the groups C=O and OH were evaluated with the aim of analysing the formation of hydrogen bond interactions. Therefore, it is possible to conclude that, without replacing the experimental trials, the computational approach can be used as a preliminary and complementary tool to experimental selection.

Les cannabinoides (CBs) et plus spécifiquement les agonistes des récepteurs CB2 ontdémontré leurs propriétés analgésiques, sans effet psychotrope comparés auxagonistes CB1. Les CBs sont généralement des composés lipophiles et non “drug-like”présentant une faible biodisponibilité. Afin d’évaluer de nouveaux CB2 agonistesd’origine synthétique développés par notre laboratoire, sur des modèles in vivo dedouleur neuropathique, une stratégie de formulation précoce a été mise au point et apermis le développement de quatre systèmes de délivrance d’actif. Une étudepharmacologique d’efficacité a été conduite avec notre tête de série MDA7, formulédans des complexes d’inclusion avec des cyclodextrines (CDs), des liposomes et unesolution micellaire administrés par voie parentérale. Le concept à base de CDs adémontré une plus forte activité anti nociceptive. Une étude de compréhension dumécanisme d’inclusion de MDA7 dans le complexe supramoléculaire formé avec lesCDs a été menée. Des systèmes auto-émulsionnables (SEDDS) ont également étéutilisés pour une administration orale afin d’étudier le profile pharmacocinétique deMDA7. Des nanocapsules (NCs) polymériques et cationiques ont également été développéesafin de stabiliser un phytocannabinoide, CB2, en vue d’une administration in vivo. Desétudes pour caractériser et évaluer l’influence des paramètres affectant la formation desNCs préparées par nanoprécipitation ont été conduites. Nous avons étudié lapropension des NCs développées à former des interactions ioniques avec desmacrocycles anioniques tels que les sulfobutylether-β-cyclodextrines ou, desinteractions électrostatiques avec les cucurbit[n]urils / Cannabinoids (CBs) and particularly CB2 agonists have been shown to reduce pain andinflammation without eliciting any apparent psychotropic effect conversely to CB1agonist compounds. CBs candidates are usually lipophilic non drug-like compoundswith poor bioavailability. To serve the purpose of evaluating new synthetic CB2 agonistsdeveloped by our group, on in vivo neuropathic pain models, an enabling formulationstrategy has been set up and four Drug Delivery Systems (DDS) developed. Forparenteral administration, cyclodextrin (CD)-based inclusion complexes, liposomes andsurfactants/co-solvents micellar solution have been investigated whereas Self-Emulsifying DDS (SEDDS) was selected for oral administration. A pharmacologicalstudy conducted with lead compound MDA7, formulated in CD-based DDS resulted inthe higher antinociceptive activity. A comprehensive study of the inclusion mechanismof MDA7 in the CD supramolecular complexes prepared was carried out. MDA7pharmacokinetic profile was also generated formulated in micellar solution and SEDDS.Besides, cationic polymeric nanocapsules (NCs) have been designed to serve as aprotective DDS for oral administration of a dietary phytocannabinoid CB2 agonist.Studies were undertaken to characterize and evaluate the influence of differentparameters on NCs formation prepared by nanoprecipitation. The cationic NCsdeveloped have been explored for their property to yield proportion of counterioniccondensation in the presence of macrocycles bearing anionic groups such assulfobutylether-beta-cyclodextrin or to form electrostatic interactions/host-guestcomplexion with cucurbit[n]uril.

Anhand einer prospektiven epidemiologischen Verlaufsstudie an einer repräsentativen Bevölkerungsstichprobe von ursprünglich 14- bis 17jährigen Jugendlichen (N=1395) werden die Häufigkeit und die Verlaufsmuster des Konsums, des Mißbrauchs und der Abhängigkeit von Cannabis untersucht. Die Jugendlichen wurden persönlich mit Hilfe eines Interviews befragt, wobei als diagnostisches Instrument das M-CIDI mit seinen DSM-IV Algorithmen verwendet wurde. Die Ergebnisse aus der Basiserhebung ergaben, daß 1995 etwa 20% aller 14- bis 17jährigen - in der Mehrzahl wiederholt - Cannabis probiert hatten und 6% der Population einen regelmäßigen Gebrauch aufweisen. Die Einjahres-Inzidenz (= Auftreten neuer Fälle) für den Cannabisgebrauch der nun 15- bis 19jährigen betrug zum Zeitpunkt der Nachuntersuchung 20,1% für die Männer und 16,3% für die Frauen. Für den regelmäßigen Gebrauch wurden Inzidenzraen von 12% (Männer) und 8,4% (Frauen) ermittelt. Die Stabilität des Konsumverhaltens zwischen der Basis- und der Nachuntersuchung war relativ hoch un stieg mit höherem Initialkonsum an. Angesichts der hohen Gebrauchsrate von 32,4% bei den 15- bis 19jährigen bei der Nachuntersuchung ergab sich im Vergleich zu anderen psychotropen Substanzen eine relativ niedrige Prävalenz für Mißbrauch und Abhängigkeit (4%). Das Vorliegen einer Diagnose bei der Erstuntersuchung weist allerdings eine relativ hohe Stabilität über die Nachuntersuchungskette auf. / The paper examines the prevalence, incidence and stability patterns of cannabis use and dependence in a prospective epidemiological study of a random community sample of adolescents, aged 14 to 17 years (N=1395) at time 1. Assesments are based on personal interviews by trained clinical psychologists using the computerized DSM-IV lifetime and 12-month change version of the M-CIDI. Results indicate that in 1995 every fifth person aged 14 to 17 years had used cannabis at least once and 6% reported regular use. The 12-month incidence rates (i.e. proportion of the sample reporting first cannabis use in the last year) among subjects, 15 to 19 years of age at time 2, was high, with 20,1% of males and 16,3% of females reporting first use. The incidence of regular use was 12,0% (males) and 8,4% (females). The stability of consumption patterns from time 1 to time 2 was high. Increasing with higher initial consumption. Given the reexamined samples overall high cannabis consumption rates of 32,4%, the prevalence of clinically manifest DSM-IV abuse and dependence was low in comparison to other psychologic drugs (4%). However there was remarkable diagnostic stability over time in this age group of those with an initial diagnosis at time 1 receiving a diagnosis again at time 2.

Ce mémoire présente l’étude de certains effets pharmacologiques de nouveaux analogues synthétiques des cannabinoïdes. Un des objectifs de longue date des recherches sur les cannabinoïdes a été la découverte de puissants analogues synthétiques de substances naturelles, qui pourraient être développés comme médicaments. Cela nécessite, entre autres, qu’ils soient exempts d’effets psychotropes qui caractérisent l’usage récréatif du Cannabis. Le moteur derrière cet objectif a été la longue histoire de l’usage du Cannabis comme substance médicale, en particulier dans le traitement de la douleur et de l’inflammation. Parmi les nombreux effets pharmacologiques des cannabinoïdes, deux sont d’un grand intérêt thérapeutique : l’effet antiprolifératif sur les cellules tumorales et l’effet anti-angiogène. Dans ce mémoire, l’étude de ces deux effets a été réalisée sur des cultures cellulaires tumorales et endothéliales humaines. Les tests de prolifération sur les deux types de cellules n’ont pas montré de cytotoxicité. Ce qui a permis de poursuivre l’étude de l’effet anti-angiogène, et qui a mis fin à l’étude de l’effet anti-tumoral. L’inhibition de l’angiogénèse a été investiguée en réalisant des tests de recolonisation d’une zone dénudée dans une monocouche de cellules endothéliales et des tests de formation de microtubules sur matrice gélifiée. L’effet anti-angiogène n’a pas pu être évalué à cause de problèmes de contamination, néanmoins certaines molécules montrent un effet anti-migratoire. L’absence de cytotoxicité et l’analogie structurale avec le -tétrahydrocannabinol encourage à continuer l’investigation des effets pharmacologiques de ces nouvelles molécules synthétiques. Il serait aussi pertinent d’étudier, dans une thèse de doctorat, les mécanismes d’actions moléculaires par lesquels agissent ces molécules. / This thesis aims to assess the pharmacological effects of new synthetic cannabinoid analogs. A long-standing goal in cannabinoid research has been the discovery of potent synthetic analogs of the natural substances that might be developed as clinically useful drugs. This requires, among other things, that they be free of the psychotropic effects that characterize the recreational use of Cannabis. An important driving force for this goal is the long history of the use of Cannabis as a medicinal agent especially in the treatment of pain and inflammation. Among the many pharmacological effects of cannabinoids, two are of great therapeutic value: the anti-proliferative effect on tumor cells and anti-angiogenic effect. In this thesis, the study of these two effects has been conducted on tumoral and endothelial culture cell. The proliferation tests on both types of cells showed no cytotoxicity. This allowed further study of the anti-angiogenic effect, and ended the study of anti-tumoral effect. Inhibition of angiogenesis has been investigated by performing recolonization tests of a denuded area on endothelial cell monolayer and microtubules formation tests on gel matrix. This effect could not be evaluated because of contamination problems; however, some molecules show anti-migration effects. The absence of cytotoxicity and structural analogy with -tetrahydrocannabinol encourages the investigation in pharmacological effects of these new synthetic molecules. It would also be interesting to study in a doctoral thesis, the molecular mechanisms of action involved.

Diss. (sammanfattning) Stockholm : Karolinska institutet, 2007. / Härtill 4 uppsatser.

Dissertation (Ph.D.)--University of South Florida, 2006. / Includes vita. Includes bibliographical references (leaves 86-105). Also available online.

Background: Background of this work was the investigation of the endocannabinoid system (ECS) in the Fmr1 knock- out (KO) mouse. The Fmr1- KO mouse is a mouse model for fragile X syndrome (FXS). FXS is the leading monogenic cause for autism spectrum disorders (ASD) in humans. The Fmr1- KO mouse displays autistic behavior such as an impaired social interaction, repetitive behavior, cognitive deficits, increased anxiety and aggressiveness. Alterations of the ECS have been suggested to play a key role in the etiopathology of a variety of neuropsychiatric disorders. Until today, little has been described about the involvement of the ECS in ASD. Interrogation: 1. Evaluating the manifestation of typical cannabinoid- induced effects in the Fmr1- KO mouse 2. Investigating the influenceability of autistic symptoms with THC treatment in the Fmr1- KO mouse 3. Analyzing the signaling cascade of the stimulated and unstimulated ECS in different brain regions of the Fmr1- KO mouse Material and Methods: Experiments were carried out on adult (12±1 weeks old) male Fmr1- KO and Fmr1- wild- type (WT) mice from the C57BL/6J- (B6)- background. N= 15 mice received THC (10mg/kg bodyweight) and N= 16 received WIN55,212 (3mg/kg bodyweight). 30min after injection, the body temperature was measured and the distance animals moved in an open field during 15min was recorded (locomotion). Then, animals were placed with their forepaws onto a horizontally fixed bar and the time remaining in this position (catalepsy) was measured. Finally animals were placed on a preheated plate and the temperature at which a pain stimulus occurred was determined (testing analgesia). All 4 experiments are called tetrad experiment. Afterwards changes in body temperature, locomotion, catalepsy and analgesia of the animals was evaluated. To explore long-term effects of THC after the tetrad, N= 15 animals were tested in a social interaction test with a female contact mouse, 10 and 20 days after THC treatment. Therefore, the tested mouse and the contact mouse were placed together into a cage and the time mice spent in social interaction (nose, body and anogential sniffing, allogrooming and body contact) was manually quantified during 6min of recorded testing time. Another group of N= 19 received a premedication of rimonabant (Cannabinoid- receptor 1 (CB1) antagonist, 3mg/kg bodyweight) 30min prior to THC treatment. Rimonabant prevents THC from binding to CB1 and therefore allows the assessment of the involvement of CB1 in mediating social behavior. Furthermore the suggestibility of context-dependent fear conditioning with THC treatment has been tested on N= 13 mice. Animals were placed into a conditioning chamber that delivered 6 short electric shocks with a 30sec pause to their paws (conditioning phase). Immediately afterwards mice received THC or placebo. 24h later contextdependent fear was evaluated by quantification of the time mice spent freezing in the conditioning-chamber (fear) without receiving foot shocks. Intraneuronal signaling of the ECS was analyzed with N= 29 animals using western blots. Quantities of phosphorylated (“activated”) protein kinases (ERK, AKT and S6) from different brain homogenates (hippocampus, striatum, cortex and cerebellum) were therefore measured after THC or placebo injection (30 minutes prior to sacrificing). Results: Cannabinoids induced hypothermia, hypolocomotion, analgesia and catalepsy in WTmice. These effects were significantly less detectable in Fmr1- KO mice. Effects of both cannabinoids, THC and WIN55,212, were comparable with a slightly greater but not significant efficiency of THC. THC treated WT- mice exhibited further reduced social interaction 10 days after treatment, an effect that was partially prevented by premedication with rimonabant. THC increased social interaction in Fmr1- KO mice comparable to the level of untreated WT- mice. THC had no effect on behavior of WT- mice in context-dependent fear conditioning. Fmr1- KO mice showed significant less contextdependent fear conditioning compared to WT- mice. THC facilitated the recognition of an anxiety-correlated context in Fmr1- KO mice comparable to untreated WT- mice. In western blots significant changes in the THC- induced signaling cascade were detectable and depending on genotype, brain-region and analyzed protein-kinase. In the hippocampus there were no changes in untreated Fmr1- KO mice compared to WT- mice. THC had no effect on activation of protein-kinases in WT- and Fmr1- KO mice. In the striatum there were no changes in untreated Fmr1- KO mice compared to WTmice. THC significantly increased activity of ERK, AKT and S6 in WT-mice and not in Fmr1- KO mice. In the cortex of untreated Fmr1- KO mice AKT showed a significantly increased activity compared to WT- mice. THC significantly increased AKT activity in WT- mice without having an effect on KO- mice. In the cerebellum there were no changes in untreated Fmr1- KO mice compared to WT- mice. THC significantly increased ERK- activity in Fmr1- KO mice but had no effect on protein kinase activity in WT- mice. Conclusion: We observed physiological cannabinoid effects in WT- mice after treatment with THC and WIN55,212. These effects are significantly attenuated in Fmr1- KO mice. This may be interpreted as a desensitization of the ECS in the Fmr1- KO mouse. At the same time it was demonstrated that THC has the potential to improve context dependent memory consolidation and to increase social interaction in the Fmr1- KO mouse. In particular the influence of THC on impaired social interaction should be a target of further investigations to find possible therapeutic options for this typical symptom of Autism. Underlying molecular mechanisms remain unclear and the analysis of THC stimulated intraneuronal signaling gave no clear indication of possible molecular alterations in the Fmr1- KO mouse.